6June - 2020TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comToday, the Covid-19 pandemic is having a significant impact on clinical trials, which is resulting in trial suspensions, terminations, and delays. Consequently, the current pharma industry is seeking out contract research organizations (CRO) that have the ability to perform virtual trials through state-of-the-art technology and software solutions. At the same time, the CRO industry is witnessing an increased adoption of eClinical solutions, artificial intelligence and machine learning-based platforms, and innovative trial designs capable of aiding the sector cope with the disruptive changes caused by the coronavirus.In the light of these developments, the largely fragmented nature of the CRO industry is shifting toward consolidation and pushing the development of better full-service models, additional strategic partnerships with leading pharmaceutical companies, and more reliable performance from preclinical services. Additionally, CROs are widening their scope of services in response to the growing demand of virtual services and helping pharma companies in their current and future endeavors. These partnerships are perfectly poised to help pharma firms and CROs in ensuring stable revenue streams in a time when consistent profitability has become difficult due to the pandemic. As today's market is brimming with a variety of CROs to choose from , leafing through this special edition of Pharma Tech Outlook will allow strategic planners and forward-thinking leaders to comprehend the evolving horizons of the CRO industry for translating partners into profits.Ushering the Era of eClinical ResearchCopyright © 2020 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.JUNE - 08 - 2020, Vol 06 - Issue 10 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405David ParkerTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >